Montelukast Prescribing at CENTRAL PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
364
Total Quantity
9,933
NHS Cost
£469
vs National Avg
-46.8%
CENTRAL PARK SURGERY prescribed 364 items of Montelukast over the last 12 months at a cost of £469 to the NHS. This is 46.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
29
Jun 2026
37
Jun 2026
30
Jun 2026
30
Jun 2026
33
Jun 2026
23
Jun 2026
39
Jun 2026
33
Jun 2026
26
Jun 2026
26
Jun 2026
30
Jun 2026
28
Prescribing Details
| Total Items | 364 |
|---|---|
| Total Quantity | 9,933 |
| Total NHS Cost | £469 |
| Presentations | 4 different forms |
| vs National Average | -46.8% |
Montelukast Prescribing Comparison
| This practice | 364 items |
|---|---|
| National average per practice | 685 items |
| Difference | -46.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.